The US Food and Drug Administration (FDA) has approved Tecentriq Hybreza (atezolizumab and hyaluronidase-tqjs) for subcutaneous (SC) injection. The product is approved for all the same indications as ...
Some results have been hidden because they may be inaccessible to you